Europroteome, RheoGene, Infocom, Ciphergen, Serenex, Aviva Biosciences | GenomeWeb

Europroteome and RheoGene to Jointly Study Targets and Markers for Colon Cancer

Europroteome and RheoGene have signed a collaboration to identify potential protein targets and diagnostic markers associated with colon cancer, the companies said last week. Although the parties did not disclose financial terms of the deal, Europroteome has the rights to develop and commercialize any products that result from the joint research project.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.